PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000974664.15321.9d |
_version_ | 1827331455476301824 |
---|---|
author | Silvia Marce Torra Aleix Méndez Antonella Luciana Sturla Miriam Ratia Anna Angona Figueras Paula Amat Francisca Ferrer-Marín Silvia Escribano Emilia Scalzulli Montserrat Cortes Sansa Esther Plensa Natalia Estrada Marta Cabezon Marco Mireia Morgades Maria Alicia Senin Magan Juan Carlos Hernandez-Boluda Eduardo Anguita Massimo Breccia Valentín García-Gutiérrez Blanca Xicoy Cirici Lurdes Zamora |
author_facet | Silvia Marce Torra Aleix Méndez Antonella Luciana Sturla Miriam Ratia Anna Angona Figueras Paula Amat Francisca Ferrer-Marín Silvia Escribano Emilia Scalzulli Montserrat Cortes Sansa Esther Plensa Natalia Estrada Marta Cabezon Marco Mireia Morgades Maria Alicia Senin Magan Juan Carlos Hernandez-Boluda Eduardo Anguita Massimo Breccia Valentín García-Gutiérrez Blanca Xicoy Cirici Lurdes Zamora |
author_sort | Silvia Marce Torra |
collection | DOAJ |
first_indexed | 2024-03-07T16:36:28Z |
format | Article |
id | doaj.art-8dad2001e1af4ba89b7deb1f863173f2 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:36:28Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-8dad2001e1af4ba89b7deb1f863173f22024-03-03T09:43:18ZengWileyHemaSphere2572-92412023-08-017e153219d10.1097/01.HS9.0000974664.15321.9d202308003-01840PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKISilvia Marce Torra0Aleix Méndez1Antonella Luciana Sturla2Miriam Ratia3Anna Angona Figueras4Paula Amat5Francisca Ferrer-Marín6Silvia Escribano7Emilia Scalzulli8Montserrat Cortes Sansa9Esther Plensa10Natalia Estrada11Marta Cabezon Marco12Mireia Morgades13Maria Alicia Senin Magan14Juan Carlos Hernandez-Boluda15Eduardo Anguita16Massimo Breccia17Valentín García-Gutiérrez18Blanca Xicoy Cirici19Lurdes Zamora201 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain2 ICO Hospitalet de Llobregat-Hospital Duran i Reynals, Hematology Department, Hospitalet de Llobregat, Spain2 ICO Hospitalet de Llobregat-Hospital Duran i Reynals, Hematology Department, Hospitalet de Llobregat, Spain3 ICO Girona-Hospital Josep Trueta, Hematology Department, Girona, Spain4 Hospital Clínico Universitario-INCLIVA de Valencia, Hematology Department, Valencia, Spain5 Hospital General Universitario Morales Messeguer-CIBERER, UCAM, Hematology-Oncology Department, Murcia, Spain6 Hospital Clínico San Carlos, IML, IdISSC, Department of Medicine, Universidad Complutense de Madrid (UCM), Hematology Department, Madrid, Spain7 Policlinico Umberto 1, Sapienza University, Hematology, Department of Precision and Translational Medicine, Rome, Italy8 Hospital General de Granollers, Hematology Department, Granollers, Spain9 Consorci Sanitaria del Maresme, Hospital de Mataró, Hematology Department, Mataró, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain2 ICO Hospitalet de Llobregat-Hospital Duran i Reynals, Hematology Department, Hospitalet de Llobregat, Spain4 Hospital Clínico Universitario-INCLIVA de Valencia, Hematology Department, Valencia, Spain6 Hospital Clínico San Carlos, IML, IdISSC, Department of Medicine, Universidad Complutense de Madrid (UCM), Hematology Department, Madrid, Spain7 Policlinico Umberto 1, Sapienza University, Hematology, Department of Precision and Translational Medicine, Rome, Italy10 Hospital Ramón y Cajal, Hematology Department, Madrid, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spainhttp://journals.lww.com/10.1097/01.HS9.0000974664.15321.9d |
spellingShingle | Silvia Marce Torra Aleix Méndez Antonella Luciana Sturla Miriam Ratia Anna Angona Figueras Paula Amat Francisca Ferrer-Marín Silvia Escribano Emilia Scalzulli Montserrat Cortes Sansa Esther Plensa Natalia Estrada Marta Cabezon Marco Mireia Morgades Maria Alicia Senin Magan Juan Carlos Hernandez-Boluda Eduardo Anguita Massimo Breccia Valentín García-Gutiérrez Blanca Xicoy Cirici Lurdes Zamora PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI HemaSphere |
title | PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI |
title_full | PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI |
title_fullStr | PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI |
title_full_unstemmed | PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI |
title_short | PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI |
title_sort | pb1962 influence of transcript types in sustained deep molecular response sdmr and treatment free remission tfr in chronic phase chronic myeloid leukemia cp cml patients treated with tki |
url | http://journals.lww.com/10.1097/01.HS9.0000974664.15321.9d |
work_keys_str_mv | AT silviamarcetorra pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT aleixmendez pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT antonellalucianasturla pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT miriamratia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT annaangonafigueras pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT paulaamat pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT franciscaferrermarin pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT silviaescribano pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT emiliascalzulli pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT montserratcortessansa pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT estherplensa pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT nataliaestrada pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT martacabezonmarco pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT mireiamorgades pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT mariaaliciaseninmagan pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT juancarloshernandezboluda pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT eduardoanguita pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT massimobreccia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT valentingarciagutierrez pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT blancaxicoycirici pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki AT lurdeszamora pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki |